OpenBilldrug price receipt

NADAC week of 2026-10-14

LEVETIRACETAM 100 MG/ML SOLN

For 473 mL

Pharmacies pay

$14.26 filed

473 × $0.03015 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$21.40 estimated

$14.26 + $2.14 (15%) + $5.00 fee per fill = $21.40

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

LEVETIRACETAM 100 MG/ML SOLN is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “levetiracetam” and “levetiracetam oral”, as its NDCs’ listings variously write the nonproprietary name, under the trade name “LEVETIRACETAM solution”.

FDA gives its dosage form as solution and its route as oral.

FDA lists 10 labelers (the companies named on the label) for its NDCs, among them PAI Holdings, LLC dba PAI Pharma, Actavis Pharma, Inc. and MAJOR PHARMACEUTICALS.

FDA lists no Established Pharmacologic Class for it.

The NADAC file of 2026-10-14 prices it under 11 NDCs (National Drug Codes); the FDA directory lists 10 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $14.26 for 473 mL (473 × $0.03015 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

The 10 labelers

LabelerNDCsPharmacies pay per unit
Actavis Pharma, Inc.1$0.03015 per ML filed
Aurobindo Pharma Limited1$0.03015 per ML filed
Bionpharma Inc.1$0.03015 per ML filed
Camber Pharmaceuticals, Inc.1$0.03015 per ML filed
Chartwell RX, LLC1$0.03015 per ML filed
MAJOR PHARMACEUTICALS1$0.03015 per ML filed
NorthStar Rx LLC1$0.03015 per ML filed
Novadoz Pharmaceuticals LLC1$0.03015 per ML filed
PAI Holdings, LLC dba PAI Pharma1$0.03015 per ML filed
QUAGEN PHARMACEUTICALS LLC1$0.03015 per ML filed
Not listed as a package in the FDA directory1$0.03015 per ML filed
All 11 NDCs, with labeler and price
  • 00121-0799-16 · PAI Holdings, LLC dba PAI Pharma · $0.03015 per ML · eff. 2026-09-23 filed
  • 00472-0235-16 · Actavis Pharma, Inc. · $0.03015 per ML · eff. 2026-09-23 filed
  • 00904-7420-16 · MAJOR PHARMACEUTICALS · $0.03015 per ML · eff. 2026-09-23 filed
  • 16714-0358-01 · NorthStar Rx LLC · $0.03015 per ML · eff. 2026-09-23 filed
  • 31722-0574-47 · Camber Pharmaceuticals, Inc. · $0.03015 per ML · eff. 2026-09-23 filed
  • 62135-0548-47 · Chartwell RX, LLC · $0.03015 per ML · eff. 2026-09-23 filed
  • 65862-0250-47 · Aurobindo Pharma Limited · $0.03015 per ML · eff. 2026-09-23 filed
  • 69452-0412-88 · Bionpharma Inc. · $0.03015 per ML · eff. 2026-09-23 filed
  • 70752-0203-12 · QUAGEN PHARMACEUTICALS LLC · $0.03015 per ML · eff. 2026-09-23 filed
  • 71093-0144-13 · not listed as a package in the FDA directory · $0.03015 per ML · eff. 2026-09-23 filed
  • 72205-0037-72 · Novadoz Pharmaceuticals LLC · $0.03015 per ML · eff. 2026-09-23 filed

Other strengths, forms and brands

17 other products in the NADAC file share an FDA nonproprietary name with LEVETIRACETAM 100 MG/ML SOLN.

ProductPharmacies pay per unitMedicare per unit
KEPPRA 1,000 MG TABLET
brand · tablet, film coated
$19.8712 per EA filed
eff. 2026-09-23
We don’t know yet
KEPPRA 100 MG/ML ORAL SOLN
brand · solution
$1.91893 per ML filed
eff. 2026-09-23
We don’t know yet
KEPPRA 250 MG TABLET
brand · tablet, film coated
$8.07857 per EA filed
eff. 2026-09-23
We don’t know yet
KEPPRA 500 MG TABLET
brand · tablet, film coated
$9.91702 per EA filed
eff. 2026-09-23
We don’t know yet
KEPPRA 750 MG TABLET
brand · tablet, film coated
$13.46136 per EA filed
eff. 2026-09-23
We don’t know yet
KEPPRA XR 500 MG TABLET
brand · tablet, film coated, extended release
$9.0242 per EA filed
eff. 2026-09-23
$10.37505 per EA filed
Part D 2024 average
KEPPRA XR 750 MG TABLET
brand · tablet, film coated, extended release
$13.48131 per EA filed
eff. 2026-09-23
$10.37505 per EA filed
Part D 2024 average
LEVETIRACETAM 1,000 MG TABLET
generic · tablet, film coated / tablet
$0.15968 per EA filed
eff. 2026-09-23
$0.26202 per EA filed
Part D 2024 average
LEVETIRACETAM 100 MG/ML SOLN this page
generic · solution
$0.03015 per ML filed
eff. 2026-09-23
We don’t know yet
LEVETIRACETAM 250 MG TABLET
generic · tablet, film coated / tablet
$0.05618 per EA filed
eff. 2026-09-23
$0.26202 per EA filed
Part D 2024 average
LEVETIRACETAM 500 MG TABLET
generic · tablet, film coated / tablet
$0.07362 per EA filed
eff. 2026-09-23
$0.26202 per EA filed
Part D 2024 average
LEVETIRACETAM 750 MG TABLET
generic · tablet, film coated / tablet
$0.10924 per EA filed
eff. 2026-09-23
$0.26202 per EA filed
Part D 2024 average
LEVETIRACETAM ER 500 MG TABLET
generic · tablet, film coated, extended release / tablet, extended release
$0.17377 per EA filed
eff. 2026-09-23
$0.52537 per EA filed
Part D 2024 average
LEVETIRACETAM ER 750 MG TABLET
generic · tablet, film coated, extended release / tablet, extended release
$0.22338 per EA filed
eff. 2026-09-23
$0.52537 per EA filed
Part D 2024 average
ROWEEPRA 500 MG TABLET
generic · tablet
$0.07362 per EA filed
eff. 2026-09-23
We don’t know yet
SPRITAM 1,000 MG TABLET
brand · tablet, for suspension
$10.199 per EA filed
eff. 2025-12-17
$10.47293 per EA filed
Part D 2024 average
SPRITAM 250 MG TABLET
brand · tablet, for suspension
$10.27223 per EA filed
eff. 2026-02-18
$10.47293 per EA filed
Part D 2024 average
SPRITAM 500 MG TABLET
brand · tablet, for suspension
$10.2412 per EA filed
eff. 2026-01-21
$10.47293 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. between 2025-12-17 and 2026-09-23 (4 dates) · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 473 mL?
NADAC prices this product per ML. The FDA NDC Directory’s package description gives 473 mL in one package for the 10 of this product’s 11 NDCs it lists (“473 mL in 1 BOTTLE (0121-0799-16)”), so the card starts at one package: 473 ML. Change it to match your prescription.